Athanor Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,089
| Closed | -$326K | – | 687 |
|
|
2020
Q2 | $326K | Buy |
+2,089
| New | +$326K | 0.02% | 378 |
|
|
2020
Q1 | – | Sell |
-4,100
| Closed | -$838K | – | 364 |
|
|
2019
Q4 | $838K | Sell |
4,100
-1,140
| -22% | -$233K | 0.04% | 159 |
|
|
2019
Q3 | $421K | Buy |
5,240
+2,640
| +102% | +$212K | 0.03% | 153 |
|
|
2019
Q2 | $245K | Buy |
+2,600
| New | +$245K | 0.03% | 108 |
|